BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 12746793)

  • 1. Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy.
    Shah SS; Rodriguez T; McGowan JP
    Clin Infect Dis; 2003 May; 36(10):e131-3. PubMed ID: 12746793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy.
    Nelson M; Azwa A; Sokwala A; Harania RS; Stebbing J
    AIDS; 2008 Jul; 22(11):1374-6. PubMed ID: 18580619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactic acidosis and antiretroviral therapy: a case report and literature review.
    Marra A; Lewi D; Lanzoni V; Wey SB; Odashiro LN; Gomes PS; Silva E
    Braz J Infect Dis; 2000 Jun; 4(3):151-5. PubMed ID: 10934499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactic acidosis secondary to nucleoside analogue antiretroviral therapy.
    Khouri S; Cushing H
    AIDS Read; 2000 Oct; 10(10):602-6. PubMed ID: 11068807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactic acidosis associated with stavudine administration: a report of five cases.
    Mokrzycki MH; Harris C; May H; Laut J; Palmisano J
    Clin Infect Dis; 2000 Jan; 30(1):198-200. PubMed ID: 10619755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of stavudine-induced lactic acidosis in 3 members of an African family.
    Fielder J; Rambiki K
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(4):236-9. PubMed ID: 20798404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).
    Songa PM; Castelnuovo B; Mugasha EB; Ocama P; Kambugu A
    Clin Infect Dis; 2007 Aug; 45(4):514-7. PubMed ID: 17638205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stavudine-induced hyperlactatemia/lactic acidosis at a tertiary communicable diseases clinic in South Africa.
    Hernández Pérez E; Dawood H
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(2):109-12. PubMed ID: 20484736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic hyperlactatemia in an HIV-positive patient: a case report and discussion.
    Antoniou T; Weisdorf T; Gough K
    CMAJ; 2003 Jan; 168(2):195-8. PubMed ID: 12538549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleoside analogue-induced fatal lactic acidosis in two HIV-infected patients in Singapore.
    Hwang SW; Leo YS
    Singapore Med J; 2001 Jun; 42(6):247-51. PubMed ID: 11547960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly active antiretroviral HIV therapy-associated fatal lactic acidosis: quantitative and qualitative mitochondrial DNA lesions with mitochondrial dysfunction in multiple organs.
    Thoden J; Lebrecht D; Venhoff N; Neumann J; Müller K; Walker UA
    AIDS; 2008 May; 22(9):1093-4. PubMed ID: 18520357
    [No Abstract]   [Full Text] [Related]  

  • 12. Nucleoside analogues and mitochondrial toxicity.
    Fleischer R; Boxwell D; Sherman KE
    Clin Infect Dis; 2004 Apr; 38(8):e79-80. PubMed ID: 15095236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for mitochondrial toxicity: lactic acidosis as proof of concept.
    Brinkman K
    J HIV Ther; 2001 Mar; 6(1):13-6. PubMed ID: 11501196
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of Tris-hydroxymethyl aminomethane in severe lactic acidosis due to highly active antiretroviral therapy: a case report.
    Marfo K; Garala M; Kvetan V; Gasperino J
    J Clin Pharm Ther; 2009 Feb; 34(1):119-23. PubMed ID: 19125910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactic acidosis associated with severe neuromuscular weakness and stavudine therapy.
    Vorasayan P; Phanthumchinda K
    J Med Assoc Thai; 2011 Apr; 94(4):501-4. PubMed ID: 21591538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lactic acidosis type B. A life-threatening adverse effect of antiretroviral therapy].
    Justesen US; Pedersen C
    Ugeskr Laeger; 2000 Aug; 162(35):4664-5. PubMed ID: 10986895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal lactic acidosis during antiretroviral therapy.
    Rey C; Prieto S; Medina A; Pérez C; Concha A; Menéndez S
    Pediatr Crit Care Med; 2003 Oct; 4(4):485-7. PubMed ID: 14525648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stavudine in antiretroviral therapy: is this the end?
    Brinkman K
    AIDS; 2009 Aug; 23(13):1727-9. PubMed ID: 19571724
    [No Abstract]   [Full Text] [Related]  

  • 19. Fatal lactic acidosis and mimicking Guillain-Barré syndrome in an adolescent with human immunodeficiency virus infection.
    Rosso R; Di Biagio A; Ferrazin A; Bassetti M; Ciravegna BW; Bassetti D
    Pediatr Infect Dis J; 2003 Jul; 22(7):668-70. PubMed ID: 12886900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactic acidosis associated with nucleoside analog therapy in an HIV-positive patient.
    Goldfarb-Rumyantzev AS; Jeyakumar A; Gumpeni R; Rubin D
    AIDS Patient Care STDS; 2000 Jul; 14(7):339-42. PubMed ID: 10935049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.